Back
Brilliance China Automotive Holdings Ltd. 10K Form
Sell
45
BCAUF
Brilliance China Automotive Holdings Ltd.
Last Price:
$0.50
Seasonality Move:
2.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BCAUF News And Ratings
See the #1 stock for the next 7 days that we like better than BCAUF
BCAUF Financial Statistics
Sales & Book Value
| Annual Sales: | $152.3M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 2.33 |
| Annual Sales: | $0.71 |
| Price / Book: | 0.65 |
Profitability
| EPS (TTM): | 0.09140 |
|---|---|
| Net Income (TTM): | $448.1M |
| Gross Margin: | $26.9M |
| Return on Equity: | 8.84% |
| Return on Assets: | 7.01% |
Brilliance China Automotive Holdings Ltd. Earnings Forecast
Key Brilliance China Automotive Holdings Ltd. Financial Ratios
-
The Gross Profit Margin over the past 33 years for BCAUF is 17.69%.
-
The Selling, General & Administrative Expenses for BCAUF have been equal to 53.13% of Gross Profit Margin.
-
The Research & Development expenses have been 5.04% of Revenue.
-
The Interest Expense is 0.12% of Operating Income.
-
The Net Earning history of BCAUF is 277.90% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 18 years.
Brilliance China Automotive Holdings Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Automobiles |
| Sector: | Consumer Discretionary |
| Current Symbol: | BCAUF |
| Website: | brillianceauto.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 7.31 |
| Quick Ratio: | 6.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 5.9 |
|---|---|
| Forward P/E Ratio: | 0 |
BCAUF Technical Analysis vs Fundamental Analysis
Sell
45
Brilliance China Automotive Holdings Ltd. (BCAUF)
is a Sell
Is Brilliance China Automotive Holdings Ltd. a Buy or a Sell?
-
Brilliance China Automotive Holdings Ltd. stock is rated a SellThe current Brilliance China Automotive Holdings Ltd. [BCAUF] share price is $0.50. The Score for BCAUF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.